- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on MRD Positive Leukemia
Total 12995 results
-
Novartis PharmaceuticalsCompletedMyelogenous Leukemia, ChronicSouth Africa, Italy, Belgium, Japan, Taiwan, Turkey, Canada, Germany, Spain, Egypt, United States, Singapore, Austria, France, Netherlands, Sweden, United Kingdom, Korea, Republic of, Hong Kong, Thailand, Russian Federation, Brazil, Hungar... and more
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, ChronicGermany, India, Japan, Korea, Republic of, Turkey, Chile, China, Spain, Australia, France, Poland, Mexico, Colombia, Belgium, Austria, Italy, Peru, Greece, Brazil, Czech Republic, Hungary, Russian Federation, Netherlands, Argentina, Den... and more
-
PfizerCompletedChronic Myelogenous LeukemiaJapan
-
Novartis PharmaceuticalsCompletedChronic Myelogenous LeukemiaCanada, Italy, United States, United Kingdom, Belgium, Germany, France, Switzerland, Austria, Denmark, Spain, Norway, Sweden, Netherlands, New Zealand, Australia
-
Korean Society of HematologyNot yet recruitingChronic Myeloid Leukemia, Chronic Phase
-
University of California, IrvineRecruitingChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous LeukemiaUnited States
-
Hackensack Meridian HealthTerminatedMyeloproliferative Disorders | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloid MalignanciesUnited States
-
Novartis PharmaceuticalsCompleted
-
Indiana University School of MedicineCompletedLymphoma, Non-Hodgkin | Leukemia, Myeloid, Acute | Acute Lymphoblastic Leukemia | Myelodysplasia | Leukemia, Myelogenous, ChronicUnited States
-
The Korean Society of Blood and Marrow TransplantationChonbuk National University Hospital; Samsung Medical Center; Seoul St. Mary's... and other collaboratorsTerminatedMyelodysplastic Syndromes | Leukemia, Myeloid, Chronic-Phase | Acute Leukemia in Remission | Leukemia, Myeloid, Accelerated-PhaseKorea, Republic of
-
Novartis PharmaceuticalsNo longer availableChronic Myelogenous LeukemiaCanada
-
University of CincinnatiNovartisWithdrawnA Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid LeukemiaAcute Myeloid Leukemia | Chronic Myeloid Leukemia, Blast CrisisUnited States
-
Bristol-Myers SquibbActive, not recruitingLeukemiaFrance, India, United States, Canada, Spain, Italy, Mexico, South Africa, United Kingdom, Korea, Republic of, Russian Federation, Australia, Argentina, Germany, Brazil, Netherlands, Romania, Singapore
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteGermany, France, United States
-
GlaxoSmithKlineCompletedLeukaemia, Myelocytic, AcuteUnited States, France
-
Fred Hutchinson Cancer CenterNational Cord Blood NetworkRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Hematopoietic and Lymphoid System Neoplasm | Blastic Plasmacytoid Dendritic Cell Neoplasm | Myeloproliferative Neoplasm | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Chronic...United States
-
University of Maryland, BaltimoreNational Cancer Institute (NCI)Completed
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsRecruitingChronic Myeloid LeukemiaUnited States
-
Novartis PharmaceuticalsRecruiting
-
FundaleuRecruiting
-
Hikma Pharmaceuticals LLCRecruiting
-
Novartis PharmaceuticalsRecruitingLeukemia, Myelogenous, Chronic, BCR-ABL Positive | Chronic Myelogenous LeukemiaDenmark, Spain, France, Germany, Lebanon, Italy, Argentina, Czechia, Portugal, United Kingdom, Brazil, Mexico, Taiwan, Austria, Canada, Korea, Republic of, Russian Federation, Turkey, United States, Singapore, Japan, Bulgaria, Poland, Romani... and more
-
Poitiers University HospitalUniversity Medical Center Groningen; Imperial College London; University of Liege and other collaboratorsRecruitingChronic Myeloid LeukemiaDenmark, China, Germany, Australia, Belgium, Brazil, Chile, Croatia, Czechia, France, Greece, Japan, Lebanon, Poland, Spain, Turkey, Austria, Belarus, Netherlands, Slovakia
-
AmgenCompletedRelapsed/Refractory Philadelphia Positive B-precursor ALLFrance, United States, Germany, Italy, United Kingdom
-
University of Auckland, New ZealandLeukaemia & Blood Cancer New ZealandActive, not recruiting
-
Incyte BioSciences FranceCompletedChronic Myeloid LeukemiaFrance
-
Medical University of GrazCompletedChronic Myeloid LeukemiaAustria
-
Novartis PharmaceuticalsCompletedLeukaemiaBelgium, Austria, Czechia, France, Germany, Israel, Russian Federation, Sweden, United Kingdom, Hungary, Ireland, Italy, Slovakia, Bulgaria, Singapore, Ukraine, Poland
-
University Hospital, BordeauxCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFrance
-
SanofiRecruitingMyelodysplastic Syndromes | Acute Lymphocytic Leukaemia | Acute Myeloid Leukaemia Refractory | Blastic Plasmacytoid Dendritic Cell NeoplasiaNetherlands, France, United States, Australia, China
-
Groupe Francophone des MyelodysplasiesAbbVieRecruitingChronic Myeloid LeukemiaFrance
-
Fundacion Espanola para la Curacion de la Leucemia...Pfizer; Roche Farma, S.ATerminatedChronic Phase-Chronic Myeloid LeukemiaSpain
-
TakedaActive, not recruitingMyeloid Leukemia, Chronic, Chronic PhaseUnited States, Spain, Taiwan, Australia, Canada, Russian Federation, Sweden, Switzerland, Germany, United Kingdom, Poland, Korea, Republic of, Argentina, Hong Kong, Singapore, Italy, Chile, Czechia, Denmark, France, Portugal
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Astex Pharmaceuticals, Inc.WithdrawnRelapsed/Refractory LeukemiasUnited States
-
University of PisaRecruiting
-
King Faisal Specialist Hospital & Research CenterCompleted
-
Emory UniversityNo longer availableAcute Myeloid Leukemia | Chronic Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
European Society for Blood and Marrow TransplantationHoffmann-La Roche; AmgenCompletedAcute Leukemia | Myelodysplastic Syndrome | Chronic Myelogenous LeukemiaGermany
-
Medical College of WisconsinH. Jean Khoury Cure CML ConsortiumRecruitingChronic Phase Chronic Myelogenous LeukemiaUnited States
-
GlaxoSmithKlineCompleted
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLeukemia, Myeloid, Acute | Leukemia, Lymphoblastic, Acute | Leukemia, Myelocytic, ChronicUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Disease | Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent Childhood Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Adult B Acute Lymphoblastic... and other conditionsUnited States
-
Novartis PharmaceuticalsRecruitingChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Augusta UniversityH. Jean Khoury Cure CML ConsortiumRecruitingLeukemia, Myeloid | Chronic Myeloid Leukemia, Chronic Phase | Adult CML | Leukemia,Myeloid, ChronicUnited States
-
Novartis PharmaceuticalsTerminatedChronic Myelogenous Leukemia - Chronic PhaseUnited States
-
Shenzhen TargetRx, Inc.Peking University People's HospitalNot yet recruitingChronic Myeloid Leukemia | Accelerated Phase CMLChina
-
Novartis PharmaceuticalsActive, not recruitingHematologic Diseases | Chronic Myelogenous Leukemia | CML | Leukemia, Myeloid ChronicTaiwan, Italy, Spain, United Kingdom, Germany, United States, Korea, Republic of, France, Russian Federation, Canada, Denmark, Poland, Portugal, Austria, Czechia
-
Nanfang Hospital of Southern Medical UniversityXiangya Hospital of Central South University; Tongji Hospital; Guangzhou First... and other collaboratorsCompletedChronic Myeloid Leukemia | Acute Leukemia | Myelodysplastic SyndromeChina